PLK4 and neuroblastoma: Although we recognize that the number of cases in this study is small, the rarity of CNS-NB, the consistency of the results corroborated by extensive meta-analysis, the novelty and the translational potential of PLK4 as a biomarker and/or a therapeutic target is suitable for further investigation.